Liver Cancer Diagnostics Global Market Report 2025

Description

Liver cancer diagnostics encompass a range of techniques utilized for the identification and assessment of liver cancer, a malignancy originating in the liver. These methods play a crucial role in the early detection and diagnosis of liver cancer, utilizing both imaging and molecular testing.

Hepatocellular carcinoma, cholangiocarcinoma, hepatoblastoma, and other related forms constitute the primary types of cancer addressed in liver cancer diagnostics. Hepatocellular carcinoma (HCC) specifically pertains to the predominant liver cancer affecting individuals with cirrhosis and preexisting chronic liver disease. The screening process involves various approaches such as laboratory testing, imaging, endoscopy, biopsy, and others. Diverse technologies, including fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), immunohistochemical (IHC), among others, are employed across different end uses, including hospitals and diagnostic laboratories, academic and research institutes, and pharmaceutical and CRO laboratories.

The liver cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides liver cancer diagnostics market statistics, including liver cancer diagnostics industry global market size, regional shares, competitors with a liver cancer diagnostics market share, detailed liver cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the liver cancer diagnostics industry. This liver cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The liver cancer diagnostics market size has grown strongly in recent years. It will grow from$9.69 billion in 2024 to $10.4 billion in 2025 at a compound annual growth rate (CAGR) of 7.3%. The growth in the historic period can be attributed to biopsy techniques and histopathology, development of biomarker detection, evolution of screening programs, advances in genetic testing, improvements in liver imaging modalities

The liver cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $13.86 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to regulatory changes and standardization, growing importance of imaging modalities, development of next-generation sequencing, expanded screening programs and awareness, rising demand for biomarker-based testing. Major trends in the forecast period include rise in incidence and prevalence, advancements in imaging technologies, focus on non-invasive diagnostics, precision medicine and personalized diagnostics, integration of artificial intelligence (AI).

The anticipated rise in the prevalence of liver cancer is set to drive the growth of the liver cancer diagnostics market. Liver cancer, characterized by the uncontrolled growth of liver cells, poses a severe health risk. Diagnostic tests for liver cancer play a crucial role in determining the extent of cancer cell spread within or around the liver following the diagnosis of primary liver carcinoma. A report from the American Cancer Society revealed an increase in new cases of liver and intrahepatic bile duct cancer among females, reaching 13,230 in 2023 in the United States. The total estimated new cases of liver cancer for 2023 in the US are 41,210, with an expected 29,380 fatalities. This underscores the pressing need for liver cancer diagnostics due to the escalating prevalence of the disease.

The growing prevalence of hepatitis B is anticipated to further boost the liver cancer diagnostics market. Hepatitis B, a viral infection affecting the liver, can lead to both acute and chronic conditions. Regular monitoring is essential for individuals with chronic hepatitis B to assess liver health and detect signs of liver damage or cancer. According to the Centers for Disease Control and Prevention, approximately 296 million people, including over 6 million children under the age of 5, are affected by hepatitis B. This growing prevalence of hepatitis B is a significant driver for the expansion of the liver cancer diagnostics market.

Key companies in the liver cancer diagnostics market are creating advanced biomarker-based assays and algorithms to enhance diagnostic accuracy and facilitate early detection. Biomarker-based assays and algorithms are diagnostic tools that employ specific biological markers to identify diseases, offering more precise and efficient diagnostic capabilities. For example, in November 2023, Roche Diagnostics, a U.S.-based biotech corporation, introduced the Elecsys PIVKA-II assay and the Elecsys GAAD algorithm. The Elecsys PIVKA-II assay identifies elevated levels of the PIVKA-II biomarker, which is linked to hepatocellular carcinoma (HCC), thereby improving early liver cancer detection in high-risk patients. Meanwhile, the Elecsys GAAD algorithm combines various diagnostic markers, including PIVKA-II and AFP, to enhance diagnostic accuracy and streamline decision-making in liver cancer detection.

In April 2023, Integrated DNA Technologies, a U.S.-based biotechnology company, acquired Archer NGS research assays for an undisclosed sum. This acquisition was intended to strengthen Integrated DNA Technologies' portfolio in next-generation sequencing (NGS), with a focus on expanding its research capabilities and enhancing assay development for genomic research. Archer, Inc. is recognized as a U.S. provider of diagnostic solutions for liver cancer.

In December 2022, Fujifilm Holdings Corporation acquired Inspirata, an oncology informatics and healthcare IT solutions provider, for an undisclosed amount. The acquisition included Dynamyx digital pathology technology and involved the integration of Inspirata's staff and clients into Fujifilm. This strategic move allows Fujifilm to expand its Synapse Enterprise Imaging portfolio, incorporating pathology data and images into electronic medical record systems to streamline cancer patient treatment and support care teams.

Major companies operating in the liver cancer diagnostics market include Abbott Laboratories, F. Hoffmann-La Roche Ltd., Qiagen NV, Thermo Fisher Scientific Inc., Siemens Healthineers, Illumina Inc., Koninklijke Philips NV, Epigenomics AG, Digna Biotech SL, Biocept Inc., Danaher Corporation, Foundation Medicine Inc., Agilent Technologies Inc., Genemed Biotechnologies Inc., Merck KGaA, Fujifilm Medical Systems USA Inc., GE Healthcare, Advanced Cell Diagnostics Inc., Oxford Gene Technology, Leica Biosystems Nussloch GmbH, Exiqon A/S, BioGenex Laboratories Inc., OncoCyte Corporation, Guardant Health Inc., Exact Sciences Corporation, Grail Inc., Freenome Holdings Inc., Natera Inc., Personal Genome Diagnostics Inc., Thrive Earlier Detection Corp

North America was the largest region in the liver cancer diagnostics market in 2024. The regions covered in the liver cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the liver cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The liver cancer diagnostics market includes revenues earned by entities by liver transplants, CT scans, and liver function tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver cancer diagnostics market also includes sales of In Vitro and Imaging Tools, AI tools, and ML tools which are used in providing liver cancer diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Liver Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on liver cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for liver cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The liver cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Hepatocellular Carcinoma; Cholangiocarcinoma; Hepatoblastoma; Other Types
2) By Screening: Laboratory Testing; Imaging; Endoscopy; Biopsy; Other Screenings
3) By Technology: Fluorescent In Situ Hybridization (FISH); Comparative Genomic Hybridization (CGH); Immunohistochemical (IHC); Other Technologies
4) By End Use: Hospitals And Diagnostic Laboratories; Academic And Research Institutes; Pharmaceutical And CRO Laboratories
Subsegments:
1) By Hepatocellular Carcinoma: Early-Stage Hepatocellular Carcinoma; Advanced-Stage Hepatocellular Carcinoma
2) By Cholangiocarcinoma: Intrahepatic Cholangiocarcinoma; Extrahepatic Cholangiocarcinoma
3) By Hepatoblastoma: Pure Hepatoblastoma; Mixed Hepatoblastoma
4) Other Types: Secondary Liver Cancer; Fibrolamellar Carcinoma
Companies Mentioned: Abbott Laboratories; F. Hoffmann-La Roche Ltd.; Qiagen NV; Thermo Fisher Scientific Inc.; Siemens Healthineers
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r24276

1. Executive Summary

2. Liver Cancer Diagnostics Market Characteristics

3. Liver Cancer Diagnostics Market Trends And Strategies

4. Liver Cancer Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Liver Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

5.1. Global Liver Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Liver Cancer Diagnostics Market Growth Rate Analysis
5.4. Global Liver Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Liver Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Liver Cancer Diagnostics Total Addressable Market (TAM)

6. Liver Cancer Diagnostics Market Segmentation

6.1. Global Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hepatocellular Carcinoma
Cholangiocarcinoma
Hepatoblastoma
Other Types
6.2. Global Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Testing
Imaging
Endoscopy
Biopsy
Other Screenings
6.3. Global Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluorescent In Situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Immunohistochemical (IHC)
Other Technologies
6.4. Global Liver Cancer Diagnostics Market, Segmentation By End Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Diagnostic Laboratories
Academic And Research Institutes
Pharmaceutical And CRO Laboratories
6.5. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatocellular Carcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Early-Stage Hepatocellular Carcinoma
Advanced-Stage Hepatocellular Carcinoma
6.6. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Cholangiocarcinoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Intrahepatic Cholangiocarcinoma
Extrahepatic Cholangiocarcinoma
6.7. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Hepatoblastoma, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pure Hepatoblastoma
Mixed Hepatoblastoma
6.8. Global Liver Cancer Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Secondary Liver Cancer
Fibrolamellar Carcinoma

7. Liver Cancer Diagnostics Market Regional And Country Analysis

7.1. Global Liver Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Liver Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Liver Cancer Diagnostics Market

8.1. Asia-Pacific Liver Cancer Diagnostics Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Liver Cancer Diagnostics Market

9.1. China Liver Cancer Diagnostics Market Overview
9.2. China Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Liver Cancer Diagnostics Market

10.1. India Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Liver Cancer Diagnostics Market

11.1. Japan Liver Cancer Diagnostics Market Overview
11.2. Japan Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Liver Cancer Diagnostics Market

12.1. Australia Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Liver Cancer Diagnostics Market

13.1. Indonesia Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Liver Cancer Diagnostics Market

14.1. South Korea Liver Cancer Diagnostics Market Overview
14.2. South Korea Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Liver Cancer Diagnostics Market

15.1. Western Europe Liver Cancer Diagnostics Market Overview
15.2. Western Europe Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Liver Cancer Diagnostics Market

16.1. UK Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Liver Cancer Diagnostics Market

17.1. Germany Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Liver Cancer Diagnostics Market

18.1. France Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Liver Cancer Diagnostics Market

19.1. Italy Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Liver Cancer Diagnostics Market

20.1. Spain Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Liver Cancer Diagnostics Market

21.1. Eastern Europe Liver Cancer Diagnostics Market Overview
21.2. Eastern Europe Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Liver Cancer Diagnostics Market

22.1. Russia Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Liver Cancer Diagnostics Market

23.1. North America Liver Cancer Diagnostics Market Overview
23.2. North America Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Liver Cancer Diagnostics Market

24.1. USA Liver Cancer Diagnostics Market Overview
24.2. USA Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Liver Cancer Diagnostics Market

25.1. Canada Liver Cancer Diagnostics Market Overview
25.2. Canada Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Liver Cancer Diagnostics Market

26.1. South America Liver Cancer Diagnostics Market Overview
26.2. South America Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Liver Cancer Diagnostics Market

27.1. Brazil Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Liver Cancer Diagnostics Market

28.1. Middle East Liver Cancer Diagnostics Market Overview
28.2. Middle East Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Liver Cancer Diagnostics Market

29.1. Africa Liver Cancer Diagnostics Market Overview
29.2. Africa Liver Cancer Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Liver Cancer Diagnostics Market, Segmentation By Screening, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Liver Cancer Diagnostics Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Liver Cancer Diagnostics Market Competitive Landscape And Company Profiles

30.1. Liver Cancer Diagnostics Market Competitive Landscape
30.2. Liver Cancer Diagnostics Market Company Profiles
- 30.2.1. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Qiagen NV Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis

31. Liver Cancer Diagnostics Market Other Major And Innovative Companies

31.1. Illumina Inc.
31.2. Koninklijke Philips NV
31.3. Epigenomics AG
31.4. Digna Biotech SL
31.5. Biocept Inc.
31.6. Danaher Corporation
31.7. Foundation Medicine Inc.
31.8. Agilent Technologies Inc.
31.9. Genemed Biotechnologies Inc.
31.10. Merck KGaA
31.11. Fujifilm Medical Systems USA Inc.
31.12. GE Healthcare
31.13. Advanced Cell Diagnostics Inc.
31.14. Oxford Gene Technology
31.15. Leica Biosystems Nussloch GmbH

32. Global Liver Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Liver Cancer Diagnostics Market

34. Recent Developments In The Liver Cancer Diagnostics Market

35. Liver Cancer Diagnostics Market High Potential Countries, Segments and Strategies

35.1 Liver Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
35.2 Liver Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
35.3 Liver Cancer Diagnostics Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer